Exhibit 31.2

                      CERTIFICATION PURSUANT TO SECTION 302
                        OF THE SARBANES-OXLEY ACT OF 2002

        I, Richard Bruggeman, certify that:

        1. I have  reviewed  this  quarterly  report on Form  10-QSB of InMedica
        Development Corporation.

        2. Based on my  knowledge,  this  quarterly  report does not contain any
        untrue  statement  of a material  fact or omit to state a material  fact
        necessary to make the  statements  made,  in light of the  circumstances
        under which such  statements  were made, not misleading  with respect to
        the period covered by this quarterly report.

        3. Based on my knowledge, the financial statements,  and other financial
        information  included in this  quarterly  report,  fairly present in all
        material  respects the financial  condition,  results of operations  and
        cash flows of the  registrant  as of, and for, the periods  presented in
        this quarterly report.

         4. The registrant's other certifying officers and I are responsible for
        establishing  and  maintaining  disclosure  controls and  procedures (as
        defined in Exchange Act Rules 13a-14 and 15d-14) for the  registrant and
        have:

         a) designed  such  disclosure  controls and  procedures  to ensure that
        material   information   relating  to  the  registrant,   including  its
        consolidated  subsidiaries,  is made known to us by others  within those
        entities,  particularly during the period in which this quarterly report
        is being prepared;

          b) evaluated the effectiveness of the registrant's disclosure controls
        and  procedures  as of a date within 90 days prior to the filing date of
        this quarterly report (the Evaluation Date); and

          c)  presented  in this  quarterly  report  our  conclusions  about the
        effectiveness  of the disclosure  controls and  procedures  based on our
        evaluation as of the Evaluation Date;

     5. The registrant's other certifying  officers and I have disclosed,  based
        on our most recent  evaluation,  to the  registrant's  auditors  and the
        audit  committee  of   registrant's   board  of  directors  (or  persons
        performing the equivalent functions):
          a) all significant deficiencies in the design or operation of internal
        controls  which  could  adversely  affect  the  registrant's  ability to
        record, process, summarize and report financial data and have identified
        for the  registrant's  auditors  any  material  weaknesses  in  internal
        controls; and

          b) any fraud,  whether or not material,  that  involves  management or
        other employees who have a significant role in the registrant's internal
        controls.

     6. The registrant's other certifying  officers and I have indicated in this
        quarterly  report  whether  or not there  were  significant  changes  in
        internal  controls or in other factors that could  significantly  affect
        internal controls  subsequent to the date of our most recent evaluation,
        including any corrective actions with regard to significant deficiencies
        and material weaknesses.

DATE: May 10, 2004


/s/ Richard Bruggeman____
Richard Bruggeman,
 Chief Financial Officer